UBS analyst Dan Leonard raised the firm’s price target on Iqvia (IQV) to $280 from $250 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- Iqvia price target raised to $290 from $265 at Truist
- IQVIA Holdings: Positioned for Growth with Strategic Innovations and Industry Recovery
- Iqvia price target raised to $273 from $254 at Stifel
- Iqvia price target raised to $260 from $245 at BofA
- Iqvia price target raised to $230 from $200 at Barclays